P-168 Retrospective comparison of efficacy and safety of docetaxel and weekly-paclitaxel as 2nd-line chemotherapy for patients with unresectable or recurrent esophageal cancer

Lignende værker

• Efficacy and Safety of Bolus 5-Fluorouracil and L-Leucovorin as Salvage Chemotherapy for Oral Fluoropyrimidine-Resistant Unresectable or Recurrent Gastric Cancer: A Single Center Experience
  af: Muranaka, Tetsuhito, et al.
  Udgivet: (2016)
• Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
  af: Muranaka, Tetsuhito, et al.
  Udgivet: (2017)
• Bi-weekly Chemotherapy of Paclitaxel and Cisplatin in Patients with Metastatic or Recurrent Esophageal Cancer
  af: Cho, Sang-Hee, et al.
  Udgivet: (2005)
• Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
  af: Lee, S-H, et al.
  Udgivet: (2004)
• Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer
  af: Nakano, Shintaro, et al.
  Udgivet: (2020)